Search
IBRANCE 100 MG, Gélule
Details
| --- | Description |
|---|---|
| Pack | Boite de 21 |
| Strength (Dosage) | 100 MG |
| Laboratory | PFIZER MAROC |
| Ingredients | Palbociclib |
| Therapeutic class | Antinéoplasique, inhibiteur séléctif des kinases CDK4/CDK6 |
| ATC code | L01XE33 |
| PPH | $2,365.70 |
| PPV | $2,412.30 |
| Refundable | Yes |
| Refund base | $2,412.30 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | IBRANCE est indiqué, en association avec le Létrozole, dans le traitement en première ligne du cancer du sein métastasique chez la femme ménopausée, positif pour le récepteur d’oestrogène (ER+) et négatif pour le récepteur 2 du facteur de croissance épidermique humain (HER2-) . |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications with one or more of the ingredients above
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem